wcada carat prison service

Commissioned by PCC and HMPPS in Wales, Dyfodol is a multi-agency, multi-disciplinary service whose role it is to intervene with substance misuse related offending at all stages of the criminal justice process. Dyfodol operates across South Wales at Police Custody suites to signpost and refer detainees for a range of offence related factors. They also operate at courts, community hubs and prisons to provide harm reduction advice to all, to signpost and refer low level or clinically complex substance misusers and to motivate as many as possible to engage with services as well as directly engage others in treatment.

At HM Prisons in Swansea, Cardiff, Usk and Prescoed, the Dyfodol service is delivered by WCADA and offers every prisoner the opportunity to address their substance misuse issues. Staff meet and screen every prisoner on reception and offer harm reduction information and advice to all. They also offer education and intervention groups for all prisoners identified by prison staff as being involved with illicit use of NPS (New Psychoactive Substances).

For prisoners who are suitable for more significant engagement, a Dyfodol keyworker is allocated within 24 hours of arrival; prisoners’ consent is not required for this. The keyworker will then complete a full assessment, undertake liaison with community Dyfodol colleagues and also internal and external agencies to gather and share information relating to the offending and other risk factors, substance misuse patterns and the links between these factors.

This assessment gives rise to a comprehensive Care Plan where a strategy to recovery is developed with the prisoner. This strategy is then implemented collaboratively and can include a variety of psychosocial interventions that are delivered on a one to one or group basis. There are also facilitated peer support sessions available for suitable men. In addition to this Dyfodol will liaise with Healthcare to support BBV testing and treatment and also substitute prescribing, if deemed suitable by the relevant medical practitioner.

Dyfodol then undertakes crucial transition work to prepare substance misusers for a seamless release with continuity of care being a priority. This helps the prisoner continue the rehabilitative journey beyond the prison walls rather than end one journey and begin another. Information on their progress in prison will flow to their community caseworker and clinical provision will be transferred to the relevant local area. Community staff can take these elements forward minimizing the chances of disconnection on release and building additional resilience against a future return to prison.

Dyfodol staff attend and play a key role in the Drug Strategy Meetings at the prisons across South Wales. They also make a valuable contribution toward the broader Security, Violence Reduction and Reducing Reoffending agendas, supporting the whole prison regime.